Mercer Global Advisors Inc. ADV Has $838,000 Holdings in Chemed Co. (NYSE:CHE)

Mercer Global Advisors Inc. ADV grew its holdings in Chemed Co. (NYSE:CHE) by 4.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,545 shares of the company’s stock after purchasing an additional 70 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Chemed were worth $838,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Rise Advisors LLC acquired a new position in Chemed in the 1st quarter worth about $26,000. GAMMA Investing LLC raised its holdings in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares in the last quarter. Mather Group LLC. acquired a new position in Chemed during the first quarter valued at approximately $67,000. EntryPoint Capital LLC raised its position in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares during the period. Finally, Janiczek Wealth Management LLC lifted its stake in shares of Chemed by 154.5% in the first quarter. Janiczek Wealth Management LLC now owns 196 shares of the company’s stock worth $126,000 after buying an additional 119 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the sale, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,744 shares of company stock valued at $3,828,231. 3.32% of the stock is owned by company insiders.

Chemed Stock Up 0.8 %

CHE opened at $600.50 on Friday. Chemed Co. has a 12-month low of $497.36 and a 12-month high of $654.62. The stock’s 50 day moving average price is $573.42 and its two-hundred day moving average price is $576.78. The firm has a market capitalization of $9.09 billion, a P/E ratio of 32.32, a price-to-earnings-growth ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. Chemed’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business earned $4.71 EPS. As a group, analysts anticipate that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s payout ratio is 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.